Results 251 to 260 of about 23,381 (306)

Medication-related osteonecrosis of the jaw in Northern Thailand: A one-year cohort study of risk factors, incidence, and healing outcomes. [PDF]

J Oral Biol Craniofac Res
Pakdeemeechai S, Kammai J, Chaipattanawan N, Imerb N.   +3 more
europepmc   +1 more source

Radiologic and Pathologic Insights into Medication-Related Osteonecrosis of the Jaw in Myeloma Patients: A Report of 3 Cases. [PDF]

Radiol Case Rep
Indermun S, Simpson J, Pedro-Beech K, Alwan J, van Rensburg LJ.   +4 more
europepmc   +1 more source

Bisphosphonate-Related Osteonecrosis of the Jaw: A 10-Year Analysis of Risk Factors and Clinical Outcomes. [PDF]

J Clin Med
Stelea CG, Bologa E, Boișteanu O, Platon AL, Stelea ȘO, Gelețu GL, Onică CA, Șulea D, Ciofu ML, Costan VV.   +9 more
europepmc   +1 more source

V-ATPase and Lysosomal Energy Sensing in Periodontitis and Medicine-Related Osteonecrosis of the Jaw. [PDF]

Biomolecules
Yang X, Holliday LS.
europepmc   +1 more source

Localized therapeutic strategy based on microRNA-21-loaded mesoporous silica nanoparticles hydrogel improves bone repair in medication-related osteonecrosis of the jaw. [PDF]

J Orthop Surg Res
Li Y, Huang S, Xing Y, Chen Z, Yu D.
europepmc   +1 more source

Hypercalcemia of Malignancy and Medication-Related Osteonecrosis of the Jaw Following Denosumab Discontinuation in Metastatic Breast Cancer: A Case Report. [PDF]

Cureus
Shazley O, Orr C.
europepmc   +1 more source

Vascular and Lymphatic Dysregulation via Non-EndoMT Col2a1 Signaling in Bisphosphonate-Related Osteonecrosis of the Jaw

Shi Y, Sun H, Guo Z, Liu X, Pei X, Wang J, Yu F, Peng X, Yuan Q, Kusumbe AP, Chen J.   +10 more
europepmc   +1 more source

Denosumab and osteonecrosis of the jaw.

Australian prescriber, 2019
openaire   +2 more sources

Management and Prevention of Medication-Related Osteonecrosis of the Jaw in Germany

Heldmaier, Wiebke
openalex   +1 more source

Position Papers on MRONJ(Medication related osteonecrosis of the jaw), What has changed? [PDF]

The Journal of The Korean Dental Association, 2023
Antiresorptives, such as bisphosphonate, denosumab, are widely prescribed drugs for the treatment of osteoporosis, os-teopenia, malignant bone metastases, multiple myeloma and Paget`s disease.
Tae-Geon Kwon
semanticscholar   +2 more sources